 | • レポートコード：MRC2-11QY05267 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はジペプチドペプチダーゼ4（DPP-4）阻害剤のグローバル市場について調査・分析したレポートです。種類別（シタグリプチン、サクサグリプチン、リナグリプチン、アログリプチン、ビルダグリプチン）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ジペプチドペプチダーゼ4（DPP-4）阻害剤の競争状況、市場シェア ・世界のジペプチドペプチダーゼ4（DPP-4）阻害剤市場：種類別市場規模 2015年-2020年（シタグリプチン、サクサグリプチン、リナグリプチン、アログリプチン、ビルダグリプチン） ・世界のジペプチドペプチダーゼ4（DPP-4）阻害剤市場：種類別市場規模予測 2021年-2026年（シタグリプチン、サクサグリプチン、リナグリプチン、アログリプチン、ビルダグリプチン） ・世界のジペプチドペプチダーゼ4（DPP-4）阻害剤市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のジペプチドペプチダーゼ4（DPP-4）阻害剤市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のジペプチドペプチダーゼ4（DPP-4）阻害剤市場分析：米国、カナダ ・ヨーロッパのジペプチドペプチダーゼ4（DPP-4）阻害剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのジペプチドペプチダーゼ4（DPP-4）阻害剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のジペプチドペプチダーゼ4（DPP-4）阻害剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのジペプチドペプチダーゼ4（DPP-4）阻害剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Eli Lilly、AstraZenica、Boehringer Ingelheim、Takeda Pharmaceutical Company、BMS ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help regulate blood glucose levels.
Januvia (Sitagliptin), Galvus (Vildagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin) are the major DPP-4 drugs in the market.
Market Analysis and Insights: Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
The global Dipeptide Peptidase 4 (DPP-4) Inhibitors market size is projected to reach US$ 9262.1 million by 2026, from US$ 9040.4 million in 2020, at a CAGR of 2.3%% during 2021-2026.
Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Scope and Market Size
Dipeptide Peptidase 4 (DPP-4) Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dipeptide Peptidase 4 (DPP-4) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dipeptide Peptidase 4 (DPP-4) Inhibitors market is segmented into
Sitagliptin
Saxagliptin
Linagliptin
Alogliptin
Vildagliptin
Segment by Application, the Dipeptide Peptidase 4 (DPP-4) Inhibitors market is segmented into
Hospitals
Clinics
Regional and Country-level Analysis
The Dipeptide Peptidase 4 (DPP-4) Inhibitors market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dipeptide Peptidase 4 (DPP-4) Inhibitors market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share Analysis
Dipeptide Peptidase 4 (DPP-4) Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dipeptide Peptidase 4 (DPP-4) Inhibitors business, the date to enter into the Dipeptide Peptidase 4 (DPP-4) Inhibitors market, Dipeptide Peptidase 4 (DPP-4) Inhibitors product introduction, recent developments, etc.
The major vendors covered:
Merck
Eli Lilly
AstraZenica
Boehringer Ingelheim
Takeda Pharmaceutical Company
BMS
…
1 Study Coverage
1.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Introduction
1.2 Market Segments
1.3 Key Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Growth Rate by Type
1.4.2 Sitagliptin
1.4.3 Saxagliptin
1.4.4 Linagliptin
1.4.5 Alogliptin
1.4.6 Vildagliptin
1.5 Market by Application
1.5.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size, Estimates and Forecasts
2.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue 2015-2026
2.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales 2015-2026
2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Competitor Landscape by Players
3.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Manufacturers
3.1.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Manufacturers (2015-2020)
3.1.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2015-2020)
3.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Manufacturers
3.2.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Manufacturers (2015-2020)
3.2.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue in 2019
3.2.5 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Manufacturers
3.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Type (2015-2020)
4.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2015-2020)
4.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2015-2020)
4.1.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast by Type (2021-2026)
4.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Application (2015-2020)
5.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2015-2020)
5.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2015-2020)
5.1.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2015-2020)
5.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast by Application (2021-2026)
5.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price Forecast by Application (2021-2026)
6 North America
6.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors by Country
6.1.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country
6.1.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Type
6.3 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Application
7 Europe
7.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors by Country
7.1.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country
7.1.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Type
7.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors by Region
8.1.1 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region
8.1.2 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Type
8.3 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Application
9 Latin America
9.1 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors by Country
9.1.1 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country
9.1.2 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Type
9.3 Central & South America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors by Country
10.1.1 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country
10.1.2 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Type
10.3 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Products Offered
11.1.5 Merck Related Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Description and Business Overview
11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Products Offered
11.2.5 Eli Lilly Related Developments
11.3 AstraZenica
11.3.1 AstraZenica Corporation Information
11.3.2 AstraZenica Description and Business Overview
11.3.3 AstraZenica Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Products Offered
11.3.5 AstraZenica Related Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Description and Business Overview
11.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Products Offered
11.4.5 Boehringer Ingelheim Related Developments
11.5 Takeda Pharmaceutical Company
11.5.1 Takeda Pharmaceutical Company Corporation Information
11.5.2 Takeda Pharmaceutical Company Description and Business Overview
11.5.3 Takeda Pharmaceutical Company Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Products Offered
11.5.5 Takeda Pharmaceutical Company Related Developments
11.6 BMS
11.6.1 BMS Corporation Information
11.6.2 BMS Description and Business Overview
11.6.3 BMS Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Products Offered
11.6.5 BMS Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Products Offered
11.1.5 Merck Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Estimates and Projections by Region
12.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Regions 2021-2026
12.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Regions 2021-2026
12.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast (2021-2026)
12.2.1 North America: Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast (2021-2026)
12.2.2 North America: Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast (2021-2026)
12.2.3 North America: Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast by Country (2021-2026)
12.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast (2021-2026)
12.3.1 Europe: Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast (2021-2026)
12.3.2 Europe: Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast (2021-2026)
12.3.3 Europe: Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast by Region (2021-2026)
12.5 Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast (2021-2026)
12.5.1 Latin America: Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast (2021-2026)
12.5.2 Latin America: Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast (2021-2026)
12.5.3 Latin America: Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dipeptide Peptidase 4 (DPP-4) Inhibitors Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Segments
Table 2. Ranking of Global Top Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Growth Rate by Type 2020-2026 (g) & (US$ Million)
Table 4. Major Manufacturers of Sitagliptin
Table 5. Major Manufacturers of Saxagliptin
Table 6. Major Manufacturers of Linagliptin
Table 7. Major Manufacturers of Alogliptin
Table 8. Major Manufacturers of Vildagliptin
Table 9. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Growth Rate by Application 2020-2026 (g)
Table 10. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Region (g) & (US$ Million): 2020 VS 2026
Table 11. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Regions 2015-2020 (g)
Table 12. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Regions (2015-2020)
Table 13. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Manufacturers (2015-2020) (g)
Table 15. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Manufacturers (2015-2020)
Table 16. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dipeptide Peptidase 4 (DPP-4) Inhibitors as of 2019)
Table 18. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Price (2015-2020) (USD/mg)
Table 21. Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Type
Table 23. Date of International Manufacturers Enter into Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2015-2020) (g)
Table 26. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Type (2015-2020)
Table 27. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Type (2015-2020)
Table 29. Dipeptide Peptidase 4 (DPP-4) Inhibitors Average Selling Price (ASP) by Type 2015-2020 (USD/mg)
Table 30. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2015-2020) (g)
Table 31. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Application (2015-2020)
Table 32. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2015-2020) (g)
Table 33. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2015-2020)
Table 34. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2015-2020)
Table 36. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2015-2020) (g)
Table 37. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2015-2020)
Table 38. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2015-2020) (g)
Table 39. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2015-2020)
Table 40. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2015-2020) (g)
Table 41. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2015-2020)
Table 42. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2015-2020)
Table 44. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2015-2020) (g)
Table 45. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2015-2020)
Table 46. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2015-2020) (g)
Table 47. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2015-2020) (g)
Table 49. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2015-2020) (g)
Table 53. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2015-2020) (g)
Table 55. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2015-2020)
Table 56. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2015-2020) (g)
Table 57. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2015-2020)
Table 60. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2015-2020) (g)
Table 61. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2015-2020)
Table 62. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2015-2020) (g)
Table 63. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2015-2020) (g)
Table 65. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2015-2020) (g)
Table 69. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2015-2020) (g)
Table 71. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2015-2020)
Table 72. Merck Corporation Information
Table 73. Merck Description and Major Businesses
Table 74. Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 75. Merck Product
Table 76. Merck Recent Development
Table 77. Eli Lilly Corporation Information
Table 78. Eli Lilly Description and Major Businesses
Table 79. Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 80. Eli Lilly Product
Table 81. Eli Lilly Recent Development
Table 82. AstraZenica Corporation Information
Table 83. AstraZenica Description and Major Businesses
Table 84. AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 85. AstraZenica Product
Table 86. AstraZenica Recent Development
Table 87. Boehringer Ingelheim Corporation Information
Table 88. Boehringer Ingelheim Description and Major Businesses
Table 89. Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 90. Boehringer Ingelheim Product
Table 91. Boehringer Ingelheim Recent Development
Table 92. Takeda Pharmaceutical Company Corporation Information
Table 93. Takeda Pharmaceutical Company Description and Major Businesses
Table 94. Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 95. Takeda Pharmaceutical Company Product
Table 96. Takeda Pharmaceutical Company Recent Development
Table 97. BMS Corporation Information
Table 98. BMS Description and Major Businesses
Table 99. BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Production (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2015-2020)
Table 100. BMS Product
Table 101. BMS Recent Development
Table 102. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Regions (2021-2026) (g)
Table 103. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share Forecast by Regions (2021-2026)
Table 104. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 105. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share Forecast by Regions (2021-2026)
Table 106. North America: Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Country (2021-2026) (g)
Table 107. North America: Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Europe: Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Country (2021-2026) (g)
Table 109. Europe: Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Asia Pacific: Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Region (2021-2026) (g)
Table 111. Asia Pacific: Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 112. Latin America: Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Country (2021-2026) (g)
Table 113. Latin America: Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Middle East and Africa: Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Forecast by Country (2021-2026) (g)
Table 115. Middle East and Africa: Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 117. Key Challenges
Table 118. Market Risks
Table 119. Main Points Interviewed from Key Dipeptide Peptidase 4 (DPP-4) Inhibitors Players
Table 120. Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers List
Table 121. Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors List
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Picture
Figure 2. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Sitagliptin Product Picture
Figure 4. Saxagliptin Product Picture
Figure 5. Linagliptin Product Picture
Figure 6. Alogliptin Product Picture
Figure 7. Vildagliptin Product Picture
Figure 8. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application in 2020 & 2026
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Dipeptide Peptidase 4 (DPP-4) Inhibitors Report Years Considered
Figure 12. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size 2015-2026 (US$ Million)
Figure 13. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales 2015-2026 (g)
Figure 14. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2015-2020)
Figure 16. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region in 2019
Figure 17. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2015-2020)
Figure 18. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region in 2019
Figure 19. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue in 2019
Figure 21. Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2015-2020)
Figure 23. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type in 2019
Figure 24. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2015-2020)
Figure 25. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type in 2019
Figure 26. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Price Range (2015-2020)
Figure 27. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2015-2020)
Figure 28. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application in 2019
Figure 29. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2015-2020)
Figure 30. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application in 2019
Figure 31. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate 2015-2020 (g)
Figure 32. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country in 2019
Figure 34. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country in 2019
Figure 35. U.S. Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 36. U.S. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 38. Canada Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Type in 2019
Figure 40. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Application in 2019
Figure 41. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate 2015-2020 (g)
Figure 42. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country in 2019
Figure 44. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country in 2019
Figure 45. Germany Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 46. Germany Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 48. France Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 50. U.K. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 52. Italy Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 54. Russia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Type in 2019
Figure 56. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Application in 2019
Figure 57. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate 2015-2020 (g)
Figure 58. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region in 2019
Figure 60. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region in 2019
Figure 61. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 62. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 64. Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 66. South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 68. India Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 70. Australia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 72. Taiwan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 74. Indonesia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 76. Thailand Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 78. Malaysia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 80. Philippines Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 82. Vietnam Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Type in 2019
Figure 84. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Application in 2019
Figure 85. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate 2015-2020 (g)
Figure 86. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country in 2019
Figure 88. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country in 2019
Figure 89. Mexico Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 90. Mexico Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 92. Brazil Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 94. Argentina Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Type in 2019
Figure 96. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Application in 2019
Figure 97. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate 2015-2020 (g)
Figure 98. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Country in 2019
Figure 101. Turkey Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 102. Turkey Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 104. Saudi Arabia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (g)
Figure 106. U.A.E Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Type in 2019
Figure 108. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Share by Application in 2019
Figure 109. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate Forecast (2021-2026) (g)
Figure 110. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate Forecast (2021-2026) (g)
Figure 112. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate Forecast (2021-2026) (g)
Figure 114. Asia Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate Forecast (2021-2026) (g)
Figure 116. Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Growth Rate Forecast (2021-2026) (g)
Figure 118. Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
DPP IV阻害剤（DPP-4阻害剤）の世界市場（～2026年） DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down the proteins that are responsible for stimulating the insulin producing cells that slows down gastric secretion. Proteins can activate the release of in…- TNF阻害剤の世界市場（～2026年） TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
- シグナル伝達阻害剤の世界市場（～2026年） Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues. Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibit…
- プロテアソーム阻害剤の世界市場（～2026年） Proteasome inhibitors are drugs that block the action of proteasomes, cellular complexes that break down proteins. Proteasome inhibitors are being studied in the treatment of cancer and are used in treating multiple myeloma. Market Analysis and Insights: Global Proteasome Inhibitors Market The globa…
- 重合阻害剤の世界市場（～2026年） Monomers are often stabilized by the addition of inhibitors to prevent polymerization initiation by light, heat and air. Asia Pacific is estimated to be the fastest growing region in the global polymerization inhibitors market owing to increasing demand for it. Market Analysis and Insights: Global P…